- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0059978

Zenberg Pharmaceuticals Private Limited
About Zenberg Pharmaceuticals Private Limited
Data last updated:
Zenberg Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 07 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24299BR2018PTC040175. Its GSTIN is 10AABCZ2970Q1ZZ (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Sudhir Kumar Singh and Gita Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Pappu Kumar Jaishwal Sadan Biscoman Colony Gaighat, Patna, Bihar, India – 800007.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.42 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹59,807 (net margin 0.9%) and EBITDA of ₹2.24 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
Zenberg Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0059978).
Company details
Recognitions & Rankings of Zenberg Pharmaceuticals
Contact details
Zenberg Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressH/O Pappu Kumar Jaishwal Sadan Biscoman Colony Gaighat, Patna, Bihar, India – 800007
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Zenberg Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zenberg Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zenberg Pharmaceuticals Private Limited, buy the company report.
Financials of Zenberg Pharmaceuticals Private Limited
FY 2025 filings availableZenberg Pharmaceuticals Private Limited reported revenue of ₹69.42 Lakh (down 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 31% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,807 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zenberg Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zenberg Pharmaceuticals Private Limited
Zenberg Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Kumar Singh | Director | 12 Jun 2023 | 3 Years 5 Months | Current |
| Gita Devi | Director | 07 Dec 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Zenberg Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zenberg Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zenberg Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCZ2970Q1ZZ | Bihar | Active | 14 Dec 2020 |
To see the full GST registrations and return filing status of Zenberg Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zenberg Pharmaceuticals Private Limited has 5 board changes on record since 2023: 2 appointments and 3 cessations. The latest: Gita Devi ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Zenberg Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 07 December 2018 (8+ years old) and is registered under CIN U24299BR2018PTC040175.
Zenberg Pharmaceuticals has 2 current directors:
- Sudhir Kumar Singh - Director
- Gita Devi - Director
The latest financial statements of Zenberg Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zenberg Pharmaceuticals is 10AABCZ2970Q1ZZ, registered in Bihar.
The CIN (Corporate Identification Number) of Zenberg Pharmaceuticals is U24299BR2018PTC040175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zenberg Pharmaceuticals was incorporated on 07 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
Gita Devi ceased to be Additional Director on 29 Sep 2024. Gita Devi was appointed as Director on 07 Dec 2023. Randhir Kumar ceased to be Director on 07 Dec 2023. Zenberg Pharmaceuticals has 5 board changes on record in total.
Yes, Zenberg Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0059978).
The registered office of Zenberg Pharmaceuticals is at HO Pappu Kumar Jaishwal Sadan Biscoman Colony Gaighat, Patna, Bihar, India – 800007.
Zenberg Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.

